| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
| mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.005 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.006 |
| mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.006 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.009 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |